James L. Gulley, M.D., Ph.D., F.A.C.P.
Laboratory of Tumor Immunology and Biology
Director, Clinical Immunotherapy Group
Senior Clinician
National Cancer Institute
Building 10, Room 5B52
Bethesda, MD 20892
Phone: 301-435-2956
Fax: 301-480-1779
gulleyj@mail.nih.gov
Dr. Gulley is a board-certified medical oncologist and director of the Clinical Immunotherapy Group at the Laboratory of Tumor Immunology and Biology at the National Cancer Institute (NCI). He is a clinical investigator within the Medical Oncology Branch. He received his medical training at Loma Linda University in its medical scientist training program where he obtained a Ph.D. with his work in tumor immunology as well as an M.D. He went to Emory University for a residency in internal medicine and then to NCI for a fellowship in medical oncology. Following his fellowship, he was retained as senior staff within NCI. Dr. Gulley has been running clinical trials in prostate cancer immunotherapy since 1999 and is an internationally recognized expert in this field.
Dr. Gulley's Clinical Trials:
NCI is currently conducting the following trials for patients with breast, lung or prostate cancer. Click on the trials below for additional details, including a summary of eligibility criteria, treatment plan, and information on how to contact the study team directly.
Back to Top
